Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Their synergistic stimulation of ACTH production and secretion by corticotrope cells could yield a several-fold higher output than due to the action of either one individually (26, 34–41, 43–47).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16)”
From Progesterone does not alter osmotic regulation of AVP (2001) · cites this paper as [16]
In the citing paper
“Furthermore, VP stimulates adrenocorticotropin hormone release through the activation of pituitary V1bR [10,11].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Schally, A. V., Arimura, A., & Kastin, A. J. (1973) · Science · doi:10.1126/science.179.4071.341 · Cited by 572
Frontiers in Neuroendocrinology
Ball, J. B. (1975) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197501000-00019 · Cited by 426
FRONTIERS IN NEUROENDOCRINOLOGY
Kennedy, G. C. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.5.719 · Cited by 357
Corticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
Self-citationHypothalamic Releasing Factors
Burgus, R. C., & Guillemin, R. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.002435 · Cited by 129
Gillies, G. E., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-521 · Cited by 106
Self-citationZimmerman, E. A., Stillman, M. A., Recht, L. D., Antunes, J. L. F., Carmel, P. W., & Goldsmith, P. C. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41872.x · Cited by 97
Gillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60
Self-citation
Research works printed but not linked: 5
- Royce, P. C. & Sayers, G. Proc. Soc. exp. Biol. Med. 142, 842–845 (1960).
- Gillies, G. & Lowry, P. J. in Interactions within the Brain-Pituitary-Adrenocortical System (eds Jones, Gilham, Dallman & Chattopadhyay) 51–61 (Academic, New York, 1979).
- Sokol, H. W. & Zimmerman, E. A. Ann. N.Y. Acad. Sci. (in the press).
- Zimmerman, E. A. in Frontiers of Neuroendocrinology Vol. 4 (eds Martini, L. & Ganong, W. F.) 25–62 (Raven, New York, 1976).
- Baertischi, A. in Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortin (eds Baertischi, A. & Driefuss, J.-J.) (Academic, London, in the press).
Cited by
Items 501–600 of 971
New insights on diagnosis and treatment of AVP deficiency
Refardt, J. C., Atila, C., & Christ‐Crain, M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09862-w · Cited by 35
“…AVP neuro-secretory pathway transports high concentrations of the hormone from parvocellular neurons to the pituitary portal system, where AVP acts synergistically with corticotropin-releasing hormone to stimulate adrenocorticotropic hormone (ACTH) release from the anterior pituitary [ 13, 14 ].”
BackgroundBao, L.-L., Jiang, W.-Q., Sun, F.-J., Wang, D., Pan, Y.-J., Song, Z., Wang, C., & Yang, J. (2014) · Neuropeptides · doi:10.1016/j.npep.2014.09.006 · Cited by 32
“AVP is implicated in amplification of pituitary ACTH secretion (Gillies et al., 1982).”
Kacheva, S., Kolk, K. S., Morgenthaler, N. G., Brabant, G. E., & Karges, W. (2014) · Clinical Endocrinology · doi:10.1111/cen.12608 · Cited by 31
Pelton, G. H., Lee, Y., & Davis, M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00669-0 · Cited by 34
Gerra, G., Volpi, R., Delsignore, R., Caccavari, R., Gaggiotti, M. T., Montani, G., Maninetti, L., Chiodera, P., & Coiro, V. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90109-g · Cited by 31
Chun, S.-J., Niijima, A., Nagai, N., & Nagai, K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00854-3 · Cited by 31
Kellner, M. B., Herzog, L., Holsboer, F., & Wiedemann, K. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00070-q · Cited by 31
Larsen, P. J., Jessop, D. S., Chowdrey, H. S., Mikkelsen, J. D., & Lightman, S. L. (1992) · Peptides · doi:10.1016/0196-9781(92)90176-4 · Cited by 31
Autelitano, D. J., Clements, J. A., Nikolaidis, I., Canny, B. J., & Funder, J. W. (1987) · Endocrinology · doi:10.1210/endo-121-5-1689 · Cited by 31
Suda, T., Nakano, Y., TOZAWA, F., Sumitomo, T., Sato, Y., Yamada, M., & Demura, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)90065-h · Cited by 31
Potter, J. F., Bannan, L. T., & Beevers, D. G. (1984) · Clinical and Experimental Hypertension · doi:10.3109/10641968409039587 · Cited by 31
New insights into the molecular mechanisms of stress
Reisine, T., Affolter, H., Rougon, G., & Barbet, J. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90180-3 · Cited by 31
Pharmacology of Neural Pathways Affecting CRH Secretion
Jones, M. T., Gillham, B., CAMPBELL, E. A., ALTAHER, A. R. H., Chuang, T. T., & Sciullo, A. D. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24958.x · Cited by 31
Roles of arginine vasotocin receptors in the brain and pituitary of submammalian vertebrates
(2013) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-407696-9.00004-x · Cited by 30
“However, in mammals, the main physiological role of AVP seems to reside in its ability to potentiate the stimulatory effect of CRF on anterior pituitary corticotrophs (Beny and Baertschi, 1982; Giguere and Labrie, 1982; Gillies et al., 1982).”
BackgroundSpiga, F., Harrison, L. R., MacSweeney, C. P., Thomson, F. J., Craighead, M., & Lightman, S. L. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0425 · Cited by 30
“Since vasopressin (AVP) activity has been reported to change during chronic stress, we investigated whether this was an important factor in HPA facilitation.”
BackgroundNair, B. B., Khant Aung, Z., Porteous, R., Prescott, M., Glendining, K. A., Jenkins, D. E., Augustine, R. A., Silva, M. S. B., Yip, S. H., Bouwer, G. T., et al. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12972 · Cited by 30
Androgen regulation of behavioral stress responses and the hypothalamic-pituitary-adrenal axis
Zuloaga, D. G., Lafrican, J. J., & Zuloaga, K. L. (2024) · Hormones and Behavior · doi:10.1016/j.yhbeh.2024.105528 · Cited by 34
Nagarajan, G., Kang, S. W., & Kuenzel, W. J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.064 · Cited by 33
Wu, C., Lv, C., Wan, Y., Li, X., Zhang, J., Li, J., & Wang, Y. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.05.013 · Cited by 31
Shimizu, T., Okada, S., Yamaguchi, N., & Yokotani, K. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.087 · Cited by 30
“Vasopressin is commonly recognized as an important neuropeptide involved in water conservation (Acher, 1993) and pituitary adrenocorticotropic hormone (ACTH) secretion (Gillies et al., 1982; Rivier et al., 1984; Antoni, 1993).”
BackgroundMerali, Z., Hayley, S. P., Kent, P., McIntosh, J. F., Bédard, T., & Anisman, H. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.025 · Cited by 34
The Hypothalamic–Pituitary–Adrenal Axis and Neuroendocrine Responses to Stress
Aguilera, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10008-3 · Cited by 45
Liposits, Z. (1990) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(11)80058-6 · Cited by 30
Potter, J. F., Bannan, L. T., & Beevers, D. G. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb03882.x · Cited by 30
Regulation of the hypothalamic-pituitary-adrenal axis by neuropeptides
Aguilera, G. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.123 · Cited by 34
Pisu, M. G., Garau, A., Olla, P., Biggio, F., Utzeri, C., Dore, R., & Serra, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12273 · Cited by 29
Hazard, D., Couty, M., & Guemene, D. D. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00070.2007 · Cited by 31
“Various experimental findings have shown that CRF is more potent than AVP in CORT release in several mammals (rats (19, 46, 59); ewes (33)).”
BackgroundResultden Boon, F. S., & Sarabdjitsingh, R. A. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.09.001 · Cited by 29
Oxytocin and vasopressin mRNA expression in rat hypothalamus following kainic acid-induced seizures
Sun, Q., Pretel, S., Applegate, C. D., & Piekut, D. T. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00466-1 · Cited by 29
van Praag, H. M. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000022115 · Cited by 33
“Both vasopressin and oxytocin potentiate CRH-mediated ACTH release (Gillies et al., 1982).”
BackgroundAnatomy of the Hypothalamo-Hypophysial Complex
Page, R. B. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50032-4 · Cited by 30
Yu, G., Chen, H., Zhao, W., Matta, S. G., & Sharp, B. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3837-07.2008 · Cited by 33
“AVP, itself a weak stimulus for ACTH secretion, acts synergistically with CRF, both in vitro (Gillies et al., 1982) and in vivo (Rivier and Vale, 1983), to enhance ACTH secretion from the anterior pituitary.”
BackgroundGuillon, G., Gaillard, R.-C., Kehrer, P., Schoenenberg, P., Muller, A. F., & Jard, S. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90001-2 · Cited by 29
Nicholson, W. E., DeCherney, G. S., Jackson, R. V., & Orth, D. N. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90006-1 · Cited by 29
Spinedi, E., & Negro-Vilar, A. F. (1984) · Endocrinology · doi:10.1210/endo-114-6-2247 · Cited by 29
Ogura, E., Kageyama, K., Hanada, K., Kasckow, J., & Suda, T. (2008) · Peptides · doi:10.1016/j.peptides.2007.11.007 · Cited by 29
Neuroendocrinology and Adaptive Physiology of Maternal Care
Smiley, K. O., Ladyman, S. R., Gustafson, P. E., Grattan, D. R., & Brown, R. S. E. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_122 · Cited by 37
Rivalland, E. T. A., Clarke, I. J., Turner, A. I., Pompolo, S., & Tilbrook, A. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.045 · Cited by 32
Liposits, Z., & Paull, W. K. (1985) · Peptides · doi:10.1016/0196-9781(85)90424-3 · Cited by 28
Watanabe, T., & Orth, D. N. (1988) · Endocrinology · doi:10.1210/endo-122-5-2299 · Cited by 34
Lan, N., Hellemans, K. G. C., Ellis, L. A., Viau, V., & Weinberg, J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.001 · Cited by 28
Hypothalamic-Pituitary-Adrenal Axis In Psychiatric Disorders
Stokes, P. E., & Sikes, C. R. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.002511 · Cited by 30
Vasopressin and Animal Behavior
Gash, D. M., Herman, J. P., & Thomas, G. J. (1987) · Springer eBooks · doi:10.1007/978-1-4615-8129-1_14 · Cited by 30
Magnocellular vasopressin and the mechanism of “Glucocorticoid escape”
Antoni, F. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00422 · Cited by 26
“It is relevant to recall here that VP synthesis is not closely controlled by adrenal corticosteroids in magnocellular neurons (35) and that the effects of low levels of CRF on corticotropes are amplified dramatically by VP (65, 77).”
BackgroundGil-Lozano, M., Romaní-Pérez, M., Outeiriño-Iglesias, V., Vigo, E., González-Matías, L. C., Brubaker, P. L., & Mallo, F. (2014) · Endocrinology · doi:10.1210/en.2013-1718 · Cited by 24
“1 mg/L) that was added to protect CRH from oxidation (23).”
BackgroundWei, R., Phillips, T. M., & Sternberg, E. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00251-5 · Cited by 28
“The paraventricular nucleus (PVN) of the hypothalamus secretes both corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) that synergistically induce pituitary adrenocorticotropin hormone (ACTH) secretion (Gillies et al., 1982).”
BackgroundCopeptin under glucagon stimulation
Lewandowski, K. C., Lewiñski, A., Skowrońska‐Jóźwiak, E., Stasiak, M., Horzelski, W., & Brabant, G. E. (2015) · Endocrine · doi:10.1007/s12020-015-0783-7 · Cited by 29
“Corticotrophin-releasing hormone (CRH) and AVP appear to have a synergistic effect resulting in ACTH and cortisol release [5, 6].”
BackgroundTHE PITUITARY‐ADRENAL RESPONSE TO CRF‐41 IS UNALTERED BY INTRAVENOUS SOMATOSTATIN IN NORMAL SUBJECTS
Stafford, P. J., Kopelman, P. G., DAVIDSON, K., McLoughlin, L., White, A. E., REES, L. H., BESSER, G. M., Coy, D. H., & Grossman, A. B. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00272.x · Cited by 26
Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.
Al‐Damluji, S., & REES, L. H. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.9.1098 · Cited by 27
NAKATSURU, K., Ohgo, S., Oki, Y., & Matsukura, S. (1991) · Brain Research · doi:10.1016/0006-8993(91)90169-v · Cited by 27
Wu, P., & Childs, G. V. (1990) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(90)90006-p · Cited by 26
Tohei, A., Watanabe, G., & Taya, K. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560395 · Cited by 25
“In addition, it is also demonstrated that AVP amplifies the effect of CRH about 2- to 3-fold, and hence the slope of a dose–response curve for CRH or AVP alone will be less than that of AVP applied in combination with CRH (Gillies et al. 1982, Rivier & Vale 1983, Vale et al. 1983).”
BackgroundNguyen, E. T., Caldwell, J. L., Streicher, J., Ghisays, V., Balmer, N. J., Estrada, C. M., & Solomon, M. B. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.045 · Cited by 26
Marty, V. N., Mulpuri, Y., Munier, J. J., & Spigelman, I. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107991 · Cited by 26
“, 1985), can synergize with CRF to amplify ACTH release (Gillies et al., 1982; Hauger and Aguilera, 1993).”
BackgroundDavies, J., Waller, S., Zeng, Q., Wells, S. E., & Murphy, D. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00865.x · Cited by 25
THE RESPONSE OF PLASMA OXYTOCIN TO SURGICAL STRESS
NUSSEY, S. S., PAGE, S. R., ANG, V. T. Y., & JENKINS, J. S. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb01213.x · Cited by 25
The neuroendocrine immunology of rheumatoid arthritis
Chikanza, I. C. (1996) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(96)80018-5 · Cited by 29
Hawtin, S. R., Wesley, V. J., Parslow, R. A., Simms, J., Miles, A., McEwan, K., & Wheatley, M. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0795 · Cited by 25
“These constructs were termed [ 2–41]V1aR, [ 2–44]V1aR and [ 2–47]V1aR, respectively, where the numbering refers to the amino acid residues deleted.”
BackgroundMethodInfluentialMeyerhoff, J. L., Oleshansky, M. A., Kalogeras, K. T., Mougey, E. H., Chrousos, G. P., & Granger, L. G. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_6 · Cited by 25
Sharp, B. M., Nicol, S. E., Cummings, S., & Seybold, V. S. (1987) · Brain Research · doi:10.1016/0006-8993(87)90945-0 · Cited by 25
Amaya, F., Tanaka, M., Tamada, Y., Tanaka, Y., Nilaver, G., & Ibata, Y. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00343-1 · Cited by 25
Evidence for intrapituitary intercellular control of adrenocorticotropin secretion
Schwartz, J. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90179-c · Cited by 25
Cameron, V. A., Espiner, E. A., Nicholls, M. G., MacFarlane, M. R., & Sadler, W. A. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90034-2 · Cited by 25
Bouchez, G., Millan, M. J., Rivet, J., Billiras, R., Boulanger, R., & Gobert, A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.010 · Cited by 28
Zelena, D., Pintér, O., Balázsfi, D., Langnaese, K., Richter, K., Landgraf, R., Makara, G. B., & Engelmann, M. (2015) · Amino Acids · doi:10.1007/s00726-015-2026-x · Cited by 24
“However, it markedly augmented ACTH release induced by CRH (Gillies et al. 1982) by amplifying the CRHevoked cAMP response (Abou-Samra et al. 1987; Giguere and Labrie 1982).”
BackgroundAguilera, G., Volpi, S., & Rabadan‐Diehl, C. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300099 · Cited by 25
THE ROLE OF MODERN BIOASSAYS IN CLINICAL ENDOCRINOLOGY
Robertson, W. R., Lambert, A. W., & Loveridge, N. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb01152.x · Cited by 24
Natural killer cell activity in vasopressin-deficient rats (brattleboro strain)
Yirmiya, R., Shavit, Y., Ben‐Eliyahu, S., Martin, F. C., Weiner, H., & Liebeskind, J. C. (1989) · Brain Research · doi:10.1016/0006-8993(89)91330-9 · Cited by 24
Linton, E. A., Gillies, G. E., & Lowry, P. J. (1983) · Endocrinology · doi:10.1210/endo-113-5-1878 · Cited by 24
Self-citationHasunuma, I., Toyoda, F., Kadono, Y., Yamamoto, K., Namiki, H., & Kikuyama, S. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1079-0 · Cited by 25
“Although AVP has ACTH-releasing activity, the main physiological role of AVP seems to reside in its ability to potentiate the effect of CRF on anterior pituitary corticotropes (Giguere and Labrie 1982; Gillies et al. 1982).”
BackgroundChen, J., Volpi, S., & Aguilera, G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.023 · Cited by 24
“Vasopressin (VP), produced mainly in magnocellular and parvocellular neurons of the hypothalamus, is an important neuropeptide involved in water conservation, blood pressure control and pituitary ACTH hormone secretion (Gilles et al., 1982; Rivier et al., 1984; Thibonnier, 1988).”
Corticotropin-Releasing Factor Receptors and Their Interacting Proteins: Functional Consequences
Slater, P. G., Yarur, H. E., & Gysling, K. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104927 · Cited by 27
“Gillies et al. (1982) showed that CRF and AVP have a synergistic effect on the release of ACTH from the pituitary, and Young et al. (2007), using coimmunoprecipitation (Co-IP) and bioluminescence resonance energy transfer (BRET) techniques, showed that V1bR and CRF1R are able to interact in Chinese…”
BackgroundEffects of CRF, AVP and opioid peptides on pituitary-adrenal responses in sheep
Brooks, A. N., & Challis, J. R. G. (1989) · Peptides · doi:10.1016/0196-9781(89)90024-7 · Cited by 23
Nishita, J. K., Ellinwood, E. H., Rockwell, W. J. K., Kuhn, C. M., Hoffman, G. W., McCall, W. V., & Manepalli, J. N. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90009-7 · Cited by 24
“Although vasopressin is known to affect the secretion of ACTH (Gillies et al. 1982; Liu et al. 1983; Buckingham 1985; Rittmaster et al. 1987), we found no significant correlations among basal pAVP, pACTH, and plasma cortisol levels that would indicate clear relationships between pAVP and pACTH secretion.”
BackgroundAmygdala kindling elevates plasma vasopressin
Greenwood, R., Meeker, R. B., & Hayward, J. N. (1991) · Brain Research · doi:10.1016/0006-8993(91)90369-7 · Cited by 23
Neuroendocrine Projections to the Median Eminence
Hoffman, G. E., Phelps, C., Khachaturian, H., & Sladek, J. R. (1986) · Current topics in neuroendocrinology · doi:10.1007/978-3-642-71461-0_5 · Cited by 24
Laue, L., Gold, P. W., Richmond, A., & Chrousos, G. P. (1991) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00268-8 · Cited by 26
Metabolic regulation by α1- and α2-adrenoceptors
Ruffolo, R. R., Jr., Nichols, A. J., & Hieble, J. P. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90001-r · Cited by 30
Glucocorticoid Regulation of Vasopressin Messenger RNA
Baldino, F., & Davis, L. G. (1986) · Springer eBooks · doi:10.1007/978-1-4615-9486-4_6 · Cited by 23
TOZAWA, F., Suda, T., YAMADA, M., USHIYAMA, T., Tomori, N., Sumitomo, T., NAKAGAMI, Y., Demura, H., & SHIZUME, K. (1988) · Endocrinology · doi:10.1210/endo-122-4-1231 · Cited by 23
Gudmand-Hoeyer, J., Timmermann, S., & Ottesen, J. T. (2014) · Mathematical Biosciences · doi:10.1016/j.mbs.2014.07.013 · Cited by 22
Poretti, M. B., Sawant, R. S., Rask‐Andersen, M., de Cúneo, M. F., Schiöth, H. B., Pérez, M. F., & Carlini, V. P. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4187-4 · Cited by 24
Kawakami, N., Otubo, A., Maejima, S., Talukder, A. H., Satoh, K., Oti, T., Takanami, K., Ueda, Y., Itoi, K., Morris, J. F., et al. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.25026 · Cited by 23
Sex-Specific Vasopressin Signaling Buffers Stress-Dependent Synaptic Changes in Female Mice
Loewen, S. P., Baimoukhametova, D. V., & Bains, J. S. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1026-20.2020 · Cited by 23
Hypothalamo-Pituitary-Adrenal Axis Sensitization after Chronic Salt Loading
Amaya, F., Tanaka, M., Hayashi, S., Tanaka, Y., & Ibata, Y. (2001) · Neuroendocrinology · doi:10.1159/000054635 · Cited by 22
Liu, J., Engler, D., Funder, J. W., & Robinson, P. J. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90231-t · Cited by 22
Characterization of high affinity binding sites for vasopressin in bovine adrenal medulla
Antoni, F. A. (1984) · Neuropeptides · doi:10.1016/0143-4179(84)90116-1 · Cited by 22
Cyanamide‐Induced Activation of the Hypothalamo‐Pituitary‐Adrenal Axis
Kinoshita, Jessop, Finn, & Harbuz (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00449.x · Cited by 22
Hillhouse, E. W., & Reichlin, S. (1990) · Brain Research · doi:10.1016/0006-8993(90)91192-j · Cited by 22
In vitro CRF activity of vasopressin analogs is not related to pressor activity
Knepel, W., Homolka, L., & Vlaskovska, M. V. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90371-0 · Cited by 22
Kageyama, K., Nigawara, T., Sakihara, S., Takayasu, S., Terui, K., Moriyama, T., & Suda, T. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-168 · Cited by 21
“Furthermore, CRH and AVP in parvocellular PVN neurons exert synergistic effects on ACTH secretion from the AP [18, 19].”
BackgroundBates, H. E., Sirek, A. S., Kiràly, M. A., Yue, J. T. Y., Montes, D. G., Matthews, S. G., & Vranić, M. (2008) · Endocrinology · doi:10.1210/en.2007-1473 · Cited by 23
“During chronic stress, arginine vasopressin (AVP) secretion from the PVN is also an important ACTH secretagogue (4, 5).”
BackgroundVasopressin Mediates Mitogenic Responses to Adrenalectomy in the Rat Anterior Pituitary
Subburaju, S., & Aguilera, G. (2007) · Endocrinology · doi:10.1210/en.2007-0103 · Cited by 22
Involvement of upstream open reading frames in regulation of rat V1bvasopressin receptor expression
Nomura, A., Iwasaki, Y., Saito, M., Aoki, Y., Yamamori, E., Ozaki, N., Tachikawa, K., Mutsuga, N., Morishita, M., Yoshida, M., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e780 · Cited by 21
Glucocorticoids, Stress, and Development
Walker, C., Welberg, L., & Plotsky, P. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50074-3 · Cited by 23
Novel Vasopressin Gene-Related Transcripts in Rat Testis
Lefebvre, D. L., & Zingg, H. H. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-645 · Cited by 21
“Other physiological functions include contraction of vascular smooth muscle (2), stimulation of glycogenolysis and fatty acid synthesis in hepatocytes (3-5), regulation of prostaglandin synthesis in renal tissues (6), modulation of CRF-induced ACTH release (7), and facilitation of short term memory (8,9).”
BackgroundCarter, D., Pardy, K., & Murphy, D. (1993) · Cellular and Molecular Neurobiology · doi:10.1007/bf00712991 · Cited by 21
Leng, G., & MacGregor, D. J. (2018) · Mathematical Biosciences · doi:10.1016/j.mbs.2018.07.008 · Cited by 22
“CRH is more potent at releasing ACTH than vasopressin, but, in combination, their effects synergise [132].”
BackgroundMontgomery, K. R., Bridi, M. S., Folts, L. M., Marx-Rattner, R., Zierden, H. C., Wulff, A. B., Kodjo, E., Thompson, S. M., & Bale, T. L. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01739-5 · Cited by 25
“While the majority of parvocellular PVN AVP neurons co-express CRF and therefore would be activated in our model, we did not examine AVP contributions or ACTH levels in these studies [156 – 158].”
Pepels, P. P. L. M., Pesman, G. J., Korsten, H., Bonga, S. E. W., & Balm, P. H. M. (2002) · Peptides · doi:10.1016/s0196-9781(02)00037-2 · Cited by 20
Metadata
- Authors
- Gillies, G. E., Linton, E. A., & Lowry, P. J.
- Affiliations
- St Bartholomew's Hospital (GB)
- ORCID
- Linton, E. A.
- Venue
- Nature
- Published
- 1982-09
- Volume
- 299
- Issue
- 5881
- Pages
- 355-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088159839
- Cited by
- 965
- References
- 20
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 16 · 2016: 20 · 2015: 12 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, vasopressin, hypothalamic neuropeptides, hypothalamic extract, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Drug Synergism, Hypothalamus, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.